» Articles » PMID: 29445689

The Effect of 3,4- Methylenedioxymethamphetamine on Expression of Neurotrophic Factors in Hippocampus of Male Rats

Overview
Specialty General Medicine
Date 2018 Feb 16
PMID 29445689
Citations 1
Authors
Affiliations
Soon will be listed here.
Abstract

3,4- methylenedioxymethamphetamine (MDMA) is a chemical derivative of amphetamine that can induce learning and memory impairment. Due to the effect of neurotrophins on memory and learning, the impact of MDMA was evaluated on the brain - derived neurotrophic factor (BDNF), neurotrophin- 4 (NT-4), and tropomyosin- related kinase B (Trk- β) expression in the hippocampus. In this study, 20 adult male Wistar rats (200-250 g) received saline (1 mL) or 10 mg/kg of MDMA intraperitoneally as single or multiple injection for 2 consecutive days per week for 2 months. Expression of BDNF, Trk-β, and NT4 were assessed using Western blotting and RT PCR methods. Our results revealed that the expression of BDNF, Trk- β, and NT4 proteins and genes significantly decreased in MDMA groups compared to the sham group (p<0.05). Furthermore, the acute group showed the lowest expression of these proteins. The results of the present study suggest that ecstasy administration may downregulate the expression of BDNF, Trk- β, and NT-4 in hippocampus, which is more extensive in case of acute treatment. It seems that in the chronic group, hippocampus was able to compensate the ecstasy- induced neurotoxicity.

Citing Articles

3,4-methylenedioxymethamphetamine (MDMA) impairs the extinction and reconsolidation of fear memory in rats.

Hake H, Davis J, Wood R, Tanner M, Loetz E, Sanchez A Physiol Behav. 2018; 199:343-350.

PMID: 30529341 PMC: 6557441. DOI: 10.1016/j.physbeh.2018.12.007.

References
1.
Smith M, Makino S, Kvetnansky R, Post R . Stress and glucocorticoids affect the expression of brain-derived neurotrophic factor and neurotrophin-3 mRNAs in the hippocampus. J Neurosci. 1995; 15(3 Pt 1):1768-77. PMC: 6578156. View

2.
Kim D, Roh S, Kim Y, Yoon S, Lee H, Han C . High concentrations of plasma brain-derived neurotrophic factor in methamphetamine users. Neurosci Lett. 2005; 388(2):112-5. DOI: 10.1016/j.neulet.2005.06.042. View

3.
Verkes R, Gijsman H, Pieters M, Schoemaker R, de Visser S, Kuijpers M . Cognitive performance and serotonergic function in users of ecstasy. Psychopharmacology (Berl). 2001; 153(2):196-202. DOI: 10.1007/s002130000563. View

4.
Renoir T, Paizanis E, El Yacoubi M, Saurini F, Hanoun N, Melfort M . Differential long-term effects of MDMA on the serotoninergic system and hippocampal cell proliferation in 5-HTT knock-out vs. wild-type mice. Int J Neuropsychopharmacol. 2008; 11(8):1149-62. DOI: 10.1017/S1461145708009048. View

5.
Hemmerle A, Dickerson J, Herring N, Schaefer T, Vorhees C, Williams M . (±)3,4-methylenedioxymethamphetamine ("ecstasy") treatment modulates expression of neurotrophins and their receptors in multiple regions of adult rat brain. J Comp Neurol. 2012; 520(11):2459-74. PMC: 3891916. DOI: 10.1002/cne.23048. View